Literature DB >> 11925456

Dietary nucleotide supplementation reduces thioacetamide-induced liver fibrosis in rats.

María José Pérez1, Antonio Suárez, Jose Antonio Gómez-Capilla, Fermín Sánchez-Medina, Angel Gil.   

Abstract

Dietary nucleotides reportedly promote functionality and repair in fibrotic liver. Liver fibrosis is characterized by an excessive accumulation of extracellular matrix components, which lead to the impairment of the hepatic function. The aim of this work was to evaluate the influence of dietary nucleotides on liver fibrosis induced by thioacetamide and to elucidate the mechanism by which nucleotides exert their protective effects. Rats consumed ad libitum 300 mg/L thioacetamide in drinking water and were pair-fed diets with (group TN) or without nucleotides (group TS) for 4 mo. Liver histology and extracellular matrix components, liver collagenase and prolyl 4-hydroxylase activities, and tissue inhibitor of metalloproteinases-1 were assessed. The degree of fibrosis was lower in group TN than in group TS. Group TN had lower hepatic concentration of hydroxyproline (P < 0.05), collagen type I (P = 0.12) and type III (P = 0.20), fibronectin (P = 0.05), laminin (P = 0.11) and desmin (P = 0.07), higher collagenolytic activity (P < 0.05), lower prolyl 4-hydroxylase activity (P < 0.05) and lower prolyl 4-hydroxylase (P = 0.10) and tissue inhibitor of metalloproteinase-1 (P = 0.06) expression than group TS. Moreover, expression of tissue inhibitor of the metalloproteinases-1 gene was lower in group TN than in group TS (P < 0.05). These data indicate that the reduction of liver fibrosis in nucleotide-supplemented rats may rely on the enhancement of collagenase activity and the reduction of collagen content and maturation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11925456     DOI: 10.1093/jn/132.4.652

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  5 in total

1.  Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases.

Authors:  Hussam Al-Humadi; Stamatios Theocharis; Ismene Dontas; Vasileios Stolakis; Apostolos Zarros; Argyro Kyriakaki; Rafal Al-Saigh; Charis Liapi
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

2.  Combined thirty-day exposure to thioacetamide and choline-deprivation alters serum antioxidant status and crucial brain enzyme activities in adult rats.

Authors:  Charis Liapi; Hussam Al-Humadi; Apostolos Zarros; Panagiota Galanopoulou; Vasileios Stolakis; Elena Gkrouzman; Zois Mellios; Nikolina Skandali; Foteini Anifantaki; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2009-08-21       Impact factor: 3.584

3.  Hepatoprotective Effects of Panus giganteus (Berk.) Corner against Thioacetamide- (TAA-) Induced Liver Injury in Rats.

Authors:  Wei-Lun Wong; Mahmood Ameen Abdulla; Kek-Heng Chua; Umah Rani Kuppusamy; Yee-Shin Tan; Vikineswary Sabaratnam
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-09       Impact factor: 2.629

4.  Nuclease-Treated Stabilized Fermentation Product of Cetobacterium somerae Improves Growth, Non-specific Immunity, and Liver Health of Zebrafish (Danio rerio).

Authors:  Mingxu Xie; Qiang Hao; Rui Xia; Rolf Erik Olsen; Einar Ringø; Yalin Yang; Zhen Zhang; Chao Ran; Zhigang Zhou
Journal:  Front Nutr       Date:  2022-07-06

5.  Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To.

Authors:  Ya-Wen Chen; Meng-Yuan Tsai; Huay-Ben Pan; Hui-Hwa Tseng; Yu-Ting Hung; Chen-Pin Chou
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.